glp 1 drugs and gallstones GLP-1 receptor agonists gallbladder disease risk: insights into molecular mechanisms and clinical implications Preventive Screening for GLP-1RA-Induced Gallstone
Description
Mounjaro/Zepbound leads to a slightly greater weight lossthe average participant lost between 15 and 20% of their starting weight
PLoS One 8, e58784
Moreover, individual metabolic characteristics, such as coexisting diabetes, obesity, or hepatic impairment, influence drug metabolism and response, underscoring the need for personalized treatment strategies
Molecular mechanisms of chondrocyte proliferation and differentiation
Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors
